Sun Pharmaceutical Industries: A press release for Lerodalcibep licensing agreement
Sun Pharmaceutical Industries (SUNPHARMA) filed a disclosure titled "A press release for Lerodalcibep licensing agreement". The company is valued at about ₹4.41 lakh crore.
What happened
Sun Pharmaceutical Industries (SUNPHARMA) filed a disclosure with the exchanges on 28 September 2026 at 08:20 AM titled "A press release for Lerodalcibep licensing agreement".
Company snapshot
Sun Pharmaceutical Industries is a large-cap company in the Healthcare sector, with a market value of about ₹4.41 lakh crore.
The stock last traded at ₹1,838, against a 52-week range of ₹1,583.7–₹2,046.9 (10.2% below the high).
Before this filing the shares had moved −3.2% over the month and −0.6% over three months. Average daily turnover over the last 20 sessions was about ₹285 crore.
Promoters held 54.48% at the end of Q1 FY27; 1.65% of promoter shares were pledged. Foreign institutions owned 14.53% and domestic institutions 22.18%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 13,851 | 2,278.6 | 9.5 |
| Q2 FY26 | 14,478 | 3,118 | 13 |
| Q3 FY26 | 15,521 | 3,368.8 | 14 |
| Q4 FY26 | 14,612 | 2,714 | 11.3 |
| Q1 FY27 | 15,300 | 2,894.8 | 12.1 |
What history shows
This is not the company's first corporate update disclosure: BCEIE has at least 12 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.7% on average the next trading day and was down 1.4% on average after five days (7 filings with price data).
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 11 Sept 2026 | Corporate update | −0.3% | +1.6% |
| 11 Sept 2026 | Corporate update | −0.3% | +1.6% |
| 9 Sept 2026 | Incorporation of a Subsidiary Company | −1.3% | −1.7% |
| 1 Sept 2026 | Corporate update | −2.7% | −5.0% |
| 6 Aug 2026 | Receipt of No-objection letters from the Stock Exchanges for… | −0.3% | −1.1% |
Market reaction so far
Since the filing, the stock has fallen 0.8%, from ₹1,852.2 before the disclosure to ₹1,838 (live price).
In the news
Recent coverage elsewhere (links open the original publisher):
- Sun Pharmaceutical Industries Stock Signals to Watch This Week
- Sun Pharmaceutical Industries rises Friday, underperforms competitors
- SUNPHARMA Outlook for the Week (September 28, 2026 – October 02, 2026)
- Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Secures Lerodalcibep Rights Across Global Markets
- Sun Pharmaceutical Industries slips Friday, underperforms competitors
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.